Amura Holdings Ltd Company Profile
Amura has two complementary technology platforms which enable rapid and innovative drug discovery. AMcoreâ„¢, the bicyclic core molecular scaffold chemistry and the computational screening and design platform, ProtoDiscoveryâ„¢. Amura has four NCE discovery programmes based on AMcoreâ„¢:An Osteoporosis programme based on cathepsin K inhibitors, A Psoriasis programme based on a cathepsin S inhibitors, A Rheumatoid Arthritis programme based on cathepsin S inhibitors, A Malaria programme based on falcipain inhibitors.Additionally Amura has an antibacterial programme based on beta-lactamase inhibitors
Location
Horizon Park, Barton Road
Comberton
Cambridgeshire
CB3 7AJ
United Kingdom
Contact
Phone: 44(0)1223 265265
Fax: 44 (0)1223 265266
Email: amura@amura.co.uk
News Articles
GrĂ¼nenthal, Amura sign new research deal
The GrĂ¼nenthal Group and Amura Therapeutics have entered into research deal focused on the areas of pain and inflammation.
[Grunenthal], [Amura] partner on protease inhibitors for pain and inflammation
UK drug discovery biotech [Amura Therapeutics Ltd.] has licensed German pharmaco [Grunenthal Group] exclusive worldwide rights to develop, manufacture, and sell its small-molecule protease inhibitors...
GrĂ¼nenthal and Amura Therapeutics LTD Sign Agreement for Research Collaboration in Pain and ...
GrĂ¼nenthal, Amura in Protease Pain Pact
Will develop cathepsin inhibitors to treat pain and inflammation
BRIEF-Sareum Holdings says not in discussions with AstraZeneca
LONDON, Nov 6 (Reuters) - Sareum Holdings PLC : * Sareum Holdings Plc : statement re share price movement * Not in discussions with AstraZeneca * Continues to focus its efforts on commercialising t...
UPDATE 1-Malaysia's Astro TV locks in cornerstones for IPO -sources
KUALA LUMPUR, Sept 20 (Reuters) - Japanese bank Nomura Holdings Inc and Singapore's Great Eastern Holdings Ltd are among the 16 cornerstone investors for the $1.5 billion listing of pay-TV firm Astro...
BOWIE, Md., April 30, 2013 (GLOBE NEWSWIRE) -- Old Line Bancshares, Inc. (Nasdaq:OLBK), the parent company of Old Line Bank, and WSB Holdings, Inc. (Nasdaq:WSB), the parent company of The Washington...
Drugs and Medications
Bbcream [E-House Korea Holdings International]
Warm sap patch [E-House Korea Holdings International]
Warm sap patch [E-House Korea Holdings International]
PubMed Articles
Abstract AIMS: The study was conducted to identify movement patterns of disease conveyors in the New Zealand pig industry. The principal objective of the study was to identify data relating to the fre...
Emergence of Culicoides obsoletus from indoor and outdoor breeding sites.
Culicoides obsoletus (Diptera: Ceratopogondae) is considered as the probable main vector of Bluetongue virus (BTV) in northern Europe. Its breeding sites are poorly documented at the present time. We...
Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells.
Genotoxicity assessment is important for predicting the carcinogenicity of chemical substances. p53R2 is a p53-regulated gene that is induced by various genotoxic stresses. We previously developed a p...
A Longitudinal Study of Salmonella Infection in Different Types of Turkey Flocks in Great Britain.
Summary Salmonella is, after Campylobacter, the most reported zoonotic pathogen in the EU. Poultry are a common source of infection to humans, and turkey flocks are commonly colonized with the organis...
Rapid detection of infection is critical to the containment and control of contagious pathogens. Passive surveillance, based on the detection of clinical signs through farmers' observations and subseq...
Clinical Trials
None
Companies
Amura has two complementary technology platforms which enable rapid and innovative drug discovery. AMcoreâ„¢, the bicyclic core molecular scaffold chemistry and the computational screening and design...
Amura has two complementary technology platforms which enable rapid and innovative drug discovery. AMcoreâ„¢, the bicyclic core molecular scaffold chemistry and the computational screening and design...
Amura Limited is an early stage, privately owned, anti-infectives company specialising in novel antibiotics to combat moderate to severe infections. The company is based in Histon, Cambridge and opera...
HealthTech Holdings, Inc. is a health information technology holding-company, with portfolio companies including HMS, MEDHOST and Sentry Healthcare Services, Inc. HealthTec...
Sabre Holdings connects people with the world's greatest travel possibilities by retailing travel products and providing distribution and technology solutions for the travel indus...
More Information about "Amura Holdings Ltd" on BioPortfolio
We have published hundreds of Amura Holdings Ltd news stories on BioPortfolio along with dozens of Amura Holdings Ltd Clinical Trials and PubMed Articles about Amura Holdings Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amura Holdings Ltd Companies in our database. You can also find out about relevant Amura Holdings Ltd Drugs and Medications on this site too.
